Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Welcure Drugs & Pharmaceuticals has informed BSE that its trading window for dealing in company securities will remain closed from October 1, 2025 until 48 hours after the declaration of unaudited standalone financial results for the half-year and Q2 ended September 30, 2025. The closure applies to all designated persons, designated employees, specified persons, and their immediate relatives. This is a standard regulatory measure under SEBI's Insider Trading Regulations, 2015.
This is a routine compliance filing with no direct impact on the stock price. It signals that the company's Q2/H1 FY26 financial results are expected to be announced soon after October 1, 2025, which investors should watch for as the next potential catalyst.